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Campylobacter spp. are isolated from animals
and birds and from the environment, particularly
surface water. Poultry have been implicated as
a major source of sporadic infection (1).
Thermophilic Campylobacter spp., particularly
Campylobacter jejuni and C. coli, are recognized
as one of the etiologic agents of acute diarrheal
disease in humans worldwide (2,3). Antimicro-
bial chemotherapy is usually reserved for patients
with advanced infection or patients prone to
relapse. Erythromycin, fluoroquinolones, and
tetracycline are the antimicrobial drugs of choice.
Bacterial resistance to antimicrobial agents,
which is increasing worldwide, is frequently
caused by the acquisition of new genes rather
than by mutation (4,5). An efficient means of
acquiring new genes is by mobile genetic
elements such as resistance (R)-plasmids and
transposons. Recently, a novel class of naturally
occurring mobile genetic elements, integrons,
have been described as vehicles for the
acquisition of antimicrobial resistance genes (5).
Horizontal and vertical transfer can occur
readily, as shown by the widespread acquisition
of these gene cassettes among the Enterobacteri-
aceae and Pseudomonas spp. Integrons comprise
two conserved structural regions (5'CS and 3'CS)
flanking an internal variable region containing
one or more site-specific recombined gene
cassettes. While most known cassette-associated
genes located distal to the 5'CS region encode
resistance to antimicrobial drugs, some cassettes
may include one or more open reading frames
whose product(s) and corresponding function(s)
remain to be defined (5). In the 3'CS downstream
of the gene cassette are two genes, one of which
encodes resistance to quaternary ammonia
compounds (qacED1), while the other is the
sulphonamide resistance determinant (sul1).
Antimicrobial resistance among Campylobacter
spp. to drugs used in the treatment of human
infection is increasing (6-8). This article reports
the results of an investigation of a collection of
Irish thermophilic Campylobacter spp. cultured
from clinical cases of gastroenteritis and from
porcine and poultry sources. We studied a
representative sample of 55 isolates (47 C. jejuni
and eight C. coli isolated between 1996 and
1998), cultured from intestinal tissue of animals
at slaughter and from human fecal samples.
Antimicrobial agent susceptibility tests were
performed by the agar diffusion method on
IsoSensitest agar (Difco, Dublin, Ireland) with
5% horse blood (9). Cultures were prepared by
inoculating colonies from a fresh, pure, 24-hour
culture into sterile distilled water to give an
inoculum turbidity equivalent to a 0.5 McFarland
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Resistance to antimicrobial agents used to treat severe Campylobacter spp.
gastroenteritis is increasing worldwide. We assessed the antimicrobial resistance
patterns of Campylobacter spp. isolates of human and animal origin. More than half
(n = 32) were resistant to sulphonamide, a feature known to be associated with the
presence of integrons. Analysis of these integrons will further our understanding of
Campylobacter spp. epidemiology.51 51 51 51 51 Vol. 6, No. 1, January–February 2000 Emerging Infectious Diseases
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Figure 1. Agarose (1.5%) gel electrophoresis in 1x TAE buffer containing 0.5 µg/ml ethidium bromide. Purified
genomic DNA was used as the template in a PCR reaction with the primers Int 1 F 5'-GGC ATC CAA GCA CGA
AG-3' and Int 1 B 5'-AAG CAG ACT TGA CCT GA-3' (12). Lane M contains an equal mixture of molecular weight
markers grades III and V (Boehringer Mannheim, Germany), Lane N is the negative containing all reaction
components with the exception of template DNA, Lane 1, Campylobacter coli CIT-H 6 (IP-I); Lane 2, Salmonella
Typhimurium DT104 CIT-F 100 (IP-C). As in A above except that the primers used were qacE?1 F 5'-AT GCA
ATA GTT GGC GAA GT-3'and qacE?1 B 5'-CAA GCT TTT GCC CAT GAA GC-3' (13). As in A above using
primers sul1 F 5'-CTT CGA TGA GAG CCG GCG GC-3' and sul1 B 5'-GCA AGG CGG AAA CCC GCG CC-3' (13).
turbidity standard. The McFarland standard
was prepared by adding 0.5 ml 0.048 M BaCl2 to
99.5 ml 0.18 M H2SO4 with constant stirring.
Samples were swabbed evenly onto agar plates
and allowed to dry. Twelve antimicrobial agents
were tested on disks. Antimicrobial drugs tested,
together with their abbreviations and
corresponding concentrations in parentheses,
included ampicillin (Ap, 10 µg/disc),
chloramphenicol (C, 10 µg/disc), ciprofloxacin
(Cp, 5 µg/disc), colistin (Ct, 25 µg/disc),
erythromycin (E, 5 µg/disc), gentamicin
(G, 10 µg/disc), nalidixic acid (Na, 30 µg/disc),
spectinomycin (Sp, 10 µg/disc), streptomycin
(S, 25 µg/disc), sulphafurazole (Su, 100 µg/disc),
tetracycline (T, 10 µg/disc), and trimethoprim
(Tm, 1.25 µg/disc). The plates containing the
antibiotic disks were incubated at 37°C under
microaerophilic conditions for 24 hours. Inhibition
zone sizes were recorded according to the
guidelines of the National Committee for Clinical
Laboratory Standards (10). Resistance profiles
were further confirmed by E-Test (AB Biodisc,
Solna, Sweden).
Briefly, 17% of all isolates were resistant to
ampicillin, 3.8% to chloramphenicol, 1.9% to
ciprofloxacin, 7.5% to colistin, 11.3% to erythromy-
cin, 1.9% to gentamicin, 17% to nalidixic acid,
77.4% to spectinomycin, 20.8% to streptomycin,
62.3% to sulphonamide, and 24.5% to tetracy-
cline. Many of the isolates tested (n = 42, 77%)
were resistant to three or more antimicrobial
agents with part of the R-type, including SSpTm
among others. Two strains, C. jejuni CIT-
H17 (R-type: ApCtENaSSpSuTTm) and C. coli
CIT-V6 (R-type: CCpENaSSpTTm), were par-
ticularly resistant (Table 1); both were resistant
to nalidixic acid, and the latter was also resistant
to ciprofloxacin. In reviewing the R-types in the
sample, the presence of sulphonamide resistance
(in 62.3% of the sample) suggested that integron-
like structures may exist in Campylobacter spp.
To test the latter hypothesis, genomic DNA
was purified from all isolates (11). Using the
oligonucleotide primers Int 1 F 5'-GGC ATC CAA
GCA CGA AG-3'and Int 1 B 5'-AAG CAG ACT
TGA CCT GA-3' designed to anneal to the 5'CS
and 3'CS flanking regions (12) of integrons, we
tested the Campylobacter spp. genome by
polymerase chain reaction (PCR) for putative
gene cassettes. Escherichia coli containing the
characterized plasmids R100.1 and R751 (13)
together with CIT-F 100, a Salmonella enterica
serotype Typhimurium DT104 strain cultured
from a contaminated food source (14), were
included as controls. Gene cassettes of 1.0-kb and
800 bp, respectively, from E. coli (data not
shown) and 1.0- and 1.1-kb (Figure 1a, lane 2),52 52 52 52 52 Emerging Infectious Diseases Vol. 6, No. 1, January–February 2000
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Isolate No. Yeara      R-type IP-profile
Campylobacter  jejuni
CIT-H6 1997 SpSuTm I
CIT-H7 1996 SpTm I
CIT-H8 1997 ApSpTm I
CIT-H9 1997 SpTm I
CIT-H10 1997 Tm I
CIT-H12 1997 NaSpTm I
CIT-H14 1997 SpTm I
CIT-H15 1996 SpTm I
CIT-H16 1997 SpTTm I
CIT-H22 1996 SpSuTm I
CIT-H25 1997 SSpTm I
CIT-H26 1997 ApSpTm I
CIT-P4 1997 TTm I
CIT-P5 1997 SpSuTm I
CIT-H30 1997 SuTTm I
CIT-H31 1996 SpSuTm I
CIT-P10 1997 SpTm I
CIT-P13 1996 NaTm I
CIT-P14 1996 SuTTm I
CIT-P15 1996 SpSuTTm I
CIT-P16 1996 ApSpSuTTm I
CIT-H29 1997 SuTm II
CIT-P7 1997 NaSuTm II
CIT-P8 1997 SpSuTm II
CIT-P9 1997 / II
CIT-P6 1997 SpSuTm III
CIT-P11 1996 NaSpTm III
CIT-P17 1997 ESpSuTm III
CIT-H11 1997 ApSpSuTm IV
CIT-H13 1997 ApCSpTm IV
CIT-P12 1996 CtNaSpSuTTm V
CIT-H24 1997 ApNaTm VI
CIT-H27 1997 NaSSpSuTm VII
Table. Isolates of Campylobacter coli and C. jejuni from which gene cassettelike structures were amplified
aYear of isolation.
bE. coli and Salmonella enterica serotype Typhimurium control strains. The former carried plasmids R100.1 and R752,
respectively, provided by D. Sandvang (13). S. Typhimurium DT104 [CIT-F 100] was previously characterized by M. Daly et al.
(14).
H, hospital isolate; P, poultry isolate; V, veterinary isolate; /, not available or not determined. Antimicrobial agents: Ap,
ampicillin; C, chloramphenicol; Cp, ciprofloxacin;  Ct, colistin; E, erythromycin; G, gentamicin; Na, nalidixic acid; S,
streptomycin; Sp, spectinomycin; Su, sulphafurazole; T, tetracycline; Tm, trimethoprim.
Isolate No. Yeara         R-type IP-profile
C. jejuni, cont’d
CIT-H1 1996 SpSuTm VIII
CIT-P1 1997 SpSuTm IX
CIT-H2 1996 SpSuTm X
CIT-H3 1997 SuTTm XI
CIT-H4 1996 SpSuTm XII
CIT-H5 1997 SuTm XIII
C. coli
CIT-P3 1996 EGSSpSuTm XIV
CIT-V3 1998 ESpTTm XIV
CIT-V6 1998 CCpENaSSpTTm XIV
CIT-V1 1998 SpSuTm XV
CIT-V4 1998 SSpTTm XVI
CIT-V5 1998 ESSuTTm XVI
CIT-V2 1998 ESSpSuTTm XVI
C. jejuni
CIT-H23 1996 SpSuTm XVII
CIT-H28 1997 CtTm XVIII
C. coli
CIT-P2 1997 SpSuTm XIX
C. jejuni
CIT-H19 1997 SpSuTm XX
CIT-H17 1996 ApCtENaSSpSuTTm XI
CIT-H21 1997 SpSuTm XXI
CIT-H32 1996 SSpSuTm XXI
CIT-H18 1997 ApCtSSpSuTm XXII
CIT-H20 1996 ApSpTm XXII
Control strainsb
Escherichia coli
[R100.1] / / A
E. coli
[R751] / / B
Salmonella Typhimurium
 CIT-F 100 1998 ACSSuT C
from  Salmonella  Typhimurium were detected
after amplification. These amplicon profiles were
designated as integron pattern (IP)-groups A, B,
and C, respectively (Table). After amplification
and conventional agarose gel analysis of all
Campylobacter  spp. isolates in the study
population, DNA amplicons of 230 bp to 1.47 kb
were detected. A total of 22 gene cassette
structures were identified (Figure 2). The most
commonly occurring amplified gene cassette
pattern was designated IP-group I, consisting of
four DNA fragments of 350 bp to 700 bp (Figure
2, lane 1 and Figure 1a, lane 1). This gene
cassette pattern was present in both poultry and
clinically derived C. jejuni, accounting for 38% of
strains. IP-group II (Figure 2, lane 2) accounted
for 7% of all C. jejuni isolates only. The IP-groups
III (Figure 2, lane 3), XIV (Figure 2, lane 14), XVI
(Figure 2, lane 16), and XX1 (Figure 2, lane 21)
each accounted for 6% of the collection, with IP-
groups XIV and XVI being unique to C. coli. All
other IP-groups (Table; Figure 2) were
represented by single isolates. A 350-bp
amplified DNA fragment was common to all
isolates, with the exception of the poultry-
derived C. coli CIT-P2 and a clinical isolate53 53 53 53 53 Vol. 6, No. 1, January–February 2000 Emerging Infectious Diseases
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Figure 2. Schematic representation of all amplified gene cassettes from Campylobacter spp. in the study
population. Roman numerals refer to the designated integron pattern (IP)-type assigned to each pattern.
C. jejuni CIT-H3. Amplicons of 230 and 250 bp
were conserved among C. coli isolates only.
Three putative gene cassettes of 243, 388,
and 466 bp were cloned after amplification by
using the Int 1 F and Int 1 B primers (4,12) as
described above. All were sequenced by
automated methods. Sequencing data showed a
short, imperfect inverted repeat element at the
3' end of the cloned fragments which represented
the 59 base element (5'-GTTRR-3'). This is the
target for site-specific recombination involved in
the insertion and excision of gene cassettes
(4,5,15). Isolates were also tested for the 5' CS
encoded integrase (int) and the 3' CS encoded
qacE 1 and sul1 genes by PCR. A DNA fragment
of 225 bp was detected after amplification and
agarose gel analysis (Figure 1b, lane 1) using
primers qacE?1 F 5'-ATC GCA ATA GTT GGC
GAA GT-3', and qacE?1 B 5'-CAA GCT TTT GCC
CAT GAA GC-3' (13). The latter fragment
corresponded with a similar sized amplicon in
S. Typhimurium (Figure 1b, lane 2). The 3'-CS
region of integrons, known to contain a sul1 gene,
was similarly tested with the primers sul1 F 5'-
CTT CGA TGA GAG CCG GCG GC-3' and sul1 B
5'-GCA AGG CGG AAA CCC GCG CC-3' (13).
When compared with an S. Typhimurium DT104
amplicon of 436 bp (Figure 1c, lane 2) (13), the
Campylobacter  spp.  sul1-primer derived DNA
fragment (Figure 1c, lane 1) appears smaller at
approximately 360 bp. Nevertheless, the latter
amplicon was consistently amplified from all
Campylobacter  spp. Smaller sul1 primer gener-
ated DNA fragments were also detected in
S.  Typhimurium after PCR and gel analysis (14).
These may derive from the partial sul1 genes
recently located in a 14-kb gene cluster on the
chromosome of S. Typhimurium (16). On probing
the  Campylobacter  spp.  sul1-primer derived
amplicon (Figure 1c, lane 1) with the
digoxigenin-labeled 436 bp S. Typhimurium sul1
DNA amplicon (Figure 1c, lane 2), no hybridizing
signal was detected (data not shown). This result
suggests that the Campylobacter spp. sul1 gene
is different when compared with S. Typhimurium.
To investigate the 5'-CS region, primers (int1 F
[Tn21]): 5'-GAA GAC GGC TGC ACT GAA CG-3'
and int1 R [Tn21]: 5'-AAA ACC GCC ACT GCG
CCG TTA-3') were designed to amplify a 1.2-kb
DNA fragment from the integrase gene of Tn21
and were tested against Campylobacter spp. and
S.  Typhimurium (as a control) (Table). The
predicted amplicon was detected in the latter,
together with two smaller amplimers of 270 bp
and 450 bp. These latter PCR products (270 bp
and 450 bp) were also identified in Campylobacter
spp. (data not shown), consistent with a deleted
form of a class 1 integrase gene in these isolates.
The DNA sequences from the amplified
cassettes (of 243 bp, 388 bp, and 463 bp) above
were also searched by using the BLAST search
tool (17). GenBank accession numbers were
assigned as follows: AF155357 (243-bp gene
cassette); AF155356 (388-bp gene cassette), and
AF152561 (463-bp gene cassette). The former
amplicon contains two open reading frames. No
corresponding sequences were identified in the
database. The 388-bp amplicon also contained
two open reading frames and did not match any
sequences when subjected to a BLAST search of54 54 54 54 54 Emerging Infectious Diseases Vol. 6, No. 1, January–February 2000
Dispatches Dispatches Dispatches Dispatches Dispatches
the current databases. Finally, the larger 463-bp
amplicon contained two incomplete open reading
frames. BLAST searches using the latter
sequence identified glycyl-tRNA synthetase
from the genome of Helicobacter pylori matching
102 (85%) of 119 nucleotides. Further character-
ization of other gene cassettes is in progress,
focusing on amplicons of 700 bp and greater.
Drug selection may promote recombina-
tional events between Campylobacter spp.,
Enterobacteriaceae and other gram-negative
organisms (15). A common habitat for these
organisms is the human and animal gastrointes-
tinal tract. Modern animal husbandry promotes
the use of large animal housing facilities,
thereby ensuring genetic interconnection be-
tween large populations of bacteria.
Campylobacter  spp. have a natural ability for
transformation (18), and in shared animal
reservoirs, interspecies transfer of DNA,
including antimicrobial resistance encoding
genes and other unrelated genes, may occur by
strategies analogous to site-specific recombina-
tion (19,20). Our findings may indicate a novel
mechanism by which unrelated DNA becomes
incorporated into cells (21). Detailed character-
ization of these integronlike structures is an
essential step in understanding the role(s) of
these novel genetic elements. The existence of
these structures may have interesting implica-
tions regarding the diversity of the Campylobacter
spp. genome and the evolution of this species.
Together with the corresponding DNA finger-
print profile (Lucey B., Fanning S., manuscript
in preparation) the variation in genetic content
and structure of these determinants may be used
as a potential tool in elucidating the epidemiol-
ogy of these pathogens (22,23).
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